COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,722 Articles (22,913 medRxiv, 8,809 bioRxiv)

Most recent first Previous |  Page 1869: Articles 18681-18690  | Next

The antibody response to SARS-CoV-2 increases over 5 months in patients with anosmia/dysgeusia
Levi, R., Ubaldi, L., Pozzi, C., Angelotti, G., Sandri, M. T., Azzolini, E., Salvatici, M., Savevski, V., Mantovani, A., Rescigno, M.
10.1101/2021.02.05.21251219 — Posted: 2021-02-08
The kinetic variations of anti-nucleocapsid antibody in SARS-CoV-2 infection
Kawada, S., Ogata, A., Kato, Y., Okamoto, M., Yamaguchi, Y., Morita, T., Kumanogoh, A.
10.1101/2021.02.05.21251208 — Posted: 2021-02-08
Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity
Sindelar, M., Stancliffe, E., Schwaiger-Haber, M., Anbukumar, D. S., Albrecht, R. A., Liu, w.-c., Adkins-Travis, K., Garcia-Sastre, A., Shriver, L. P., Patti, G. J.
10.1101/2021.02.05.21251173 — Posted: 2021-02-08
Impact of cobas PCR Media Freezing on SARS-CoV-2 Viral RNA Integrity and Whole Genome Sequencing Analyses
Benoit, P., Point, F., Gagnon, S., Kaufmann, D. E., Tremblay, C., Harrigan, P. R., Hardy, I., Coutlee, F., Grandjean Lapierre, S.
10.1101/2021.02.05.430022 — Posted: 2021-02-08
Recombinant chimpanzee adenovirus AdC7 expressing dimeric tandem-repeat RBD of SARS-CoV-2 spike protein protects mice against COVID-19
Xu, K., An, Y., Li, Q., Huang, W., Han, Y., Zheng, T., Fang, F., Liu, H., Liu, C., Gao, P., Xu, S., Liu, W. J., Bi, Y., Wang, Y., Zhou, D., Wang, Q., Hou, W., Xia, Q., Gao, G. F., Dai, L.
10.1101/2021.02.05.429860 — Posted: 2021-02-08
Development and validation of an algorithm to estimate the risk of severe complications of COVID-19 to prioritise vaccination
Herings, R. M., Swart, K. M. A., van der Zeijst, B., van der Heijden, A. A., van der Velden, K., Hiddink, E. G., Heymans, M. W., Herings, R. A. R., van Hout, H. P. J., Beulens, J. J. W., Nijpels, G., Elders, P. J. M.
10.1101/2021.02.05.21251197 — Posted: 2021-02-08
Mapping internet activity in Australian cities during COVID-19 lockdown: how occupational factors drive inequality
Zachreson, C., Martino, E., Tomko, M., Shearer, F. M., Bentley, R., Geard, N.
10.1101/2021.02.04.21251171 — Posted: 2021-02-08
A mechanistic and data-driven reconstruction of the time-varying reproduction number: Application to the COVID-19 epidemic
Cazelles, B., Champagne, C., Nguyen Van Yen, B., Comiskey, C., Vergu, E., Roche, B.
10.1101/2021.02.04.21251167 — Posted: 2021-02-08
Staff-Pupil SARS-CoV-2 Infection Pathways in Schools: A Population Level Linked Data Approach
Thompson, D. A., Abbasizanjani, H., Fry, R., Marchant, E., Griffiths, L. J., Akbari, A., Hollinghurst, J., North, L., Lyons, J., Torabi, F., Davies, G., Gravenor, M. B., Lyons, R. A.
10.1101/2021.02.04.21251087 — Posted: 2021-02-08
Enhancing Food Security for Families Vulnerable to COVID-19
Fabusuyi, T., Misra, A., Martinez, J., Chen, A., Jiang, V., Jagadish, H. V., Hampshire, R. C.
10.1101/2021.02.04.21251181 — Posted: 2021-02-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).